The prevailing theory posits that an imbalance between the production and clearance of Aβ serves as the initiating factor, playing a crucial role in triggering other observed abnormalities in AD, while the tau protein emerges as a subsequent pathological event, further exacerbating neurodegeneration thereafter [33]. The gene discussed is MAPT; the disease is Alzheimer disease.